CAR‐DC cells specifically target multiple myeloma cells overexpressing BCMA receptors. They selectively bind to these malignant cells and enhance TRAIL‐mediated apoptosis, thereby effectively eliminating multiple myeloma cells for therapeutic purposes. This evidence concerns the gene TNFSF10 and AL amyloidosis.